$9.10-0.02 (-0.27%)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Haleon plc in the Healthcare sector is trading at $9.10. Wall Street consensus targets $11.74 (5 analysts), implying a +29.1% move over the next 12 months. The stock is currently near its 52-week low of $8.65, remaining 5.6% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Total Revenue | β | β | $2.76Bβ | $2.78Bβ | $2.77B |
| Gross Profit | β | β | $1.53Bβ | $1.75Bβ | $1.71B |
| Operating Income | β | β | $350.00Mβ | $705.00Mβ | $496.00M |
| Net Income | β | β | $231.00Mβ | $485.00Mβ | $303.00M |
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers...
US equity futures were edging higher pre-bell Monday as President Donald Trump tried to hold togethe
The facility to make oral-health products in Madhya Pradesh is the largest plant the company has taken on.
LCUT vs. HLN: Which Stock Is the Better Value Option?
LCUT vs. HLN: Which Stock Is the Better Value Option?
Haleon PLC (NYSE:HLN) is one of the best large cap penny stocks under $10 to buy now. Haleon PLC (NYSE:HLN) reported its Q1 2026 results on April 29. The results showed strong growth in the oral health segment and difficulties in the digestive health, respiratory health, and pain relief segments. But even with that, the [β¦]